Catalyst Pharmaceuticals, Inc.
CPRXDelisted Jul 15, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001369568
Catalyst Pharmaceuticals, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 396 institutions reported holding it in 13F filings for Q2 2026, worth $3.39B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q1 2023
Institutional positions in Catalyst Pharmaceuticals, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 260
- +5 vs. Q4 2022
- Shares held
- 87.9M
- +3.81M (+4.5%) vs. Q4 2022
- Total value
- $1.47B
- −$90.4M (−5.8%) vs. Q4 2022
- New holders
- 47
- 93 more added
- Sold out
- 42
- 84 more reduced
2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CPRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 396 | $3.39B |
| Q1 2026 | 382 | $2.59B |
| Q4 2025 | 375 | $2.43B |
| Q3 2025 | 360 | $2.04B |
| Q2 2025 | 365 | $2.20B |
| Q1 2025 | 370 | $2.37B |
| Q4 2024 | 336 | $2.04B |
| Q3 2024 | 316 | $1.90B |
| Q2 2024 | 271 | $1.50B |
| Q1 2024 | 268 | $1.53B |
| Q4 2023 | 259 | $1.42B |
| Q3 2023 | 256 | $948.8M |
| Q2 2023 | 248 | $1.11B |
| Q1 2023 | 260 | $1.47B |
| Q4 2022 | 257 | $1.56B |
| Q3 2022 | 229 | $1.09B |
| Q2 2022 | 190 | $531.7M |
| Q1 2022 | 186 | $585.5M |
| Q4 2021 | 164 | $446.7M |
| Q3 2021 | 144 | $345.1M |
| Q2 2021 | 139 | $376.6M |
| Q1 2021 | 133 | $312.0M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Catalyst Pharmaceuticals, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Comerica Bank | – | – | – | – | Not filed |
| CoreCap Advisors, LLC | – | – | – | – | Not filed |